Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CD2AP mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CD2AP mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CD2AP mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CD2AP mRNA | affects expression | 16483693
|
C057862 |
cyanoginosin LR |
cyanoginosin LR results in increased expression of CD2AP mRNA | increases expression | 17654400
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of CD2AP mRNA | increases expression | 16636307
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of CD2AP protein | increases expression | 16636307
|
D004317 |
Doxorubicin |
Lisinopril inhibits the reaction [Doxorubicin results in increased expression of CD2AP protein] | decreases reaction|increases expression | 16636307
|
D004317 |
Doxorubicin |
Prednisone affects the reaction [Doxorubicin results in increased expression of CD2AP mRNA] | affects reaction|increases expression | 16636307
|
D004317 |
Doxorubicin |
Prednisone inhibits the reaction [Doxorubicin results in increased expression of CD2AP protein] | decreases reaction|increases expression | 16636307
|
D004317 |
Doxorubicin |
Tretinoin affects the reaction [Doxorubicin results in increased expression of CD2AP mRNA] | affects reaction|increases expression | 16636307
|
D004317 |
Doxorubicin |
Tretinoin inhibits the reaction [Doxorubicin results in increased expression of CD2AP protein] | decreases reaction|increases expression | 16636307
|
D017706 |
Lisinopril |
Lisinopril inhibits the reaction [Doxorubicin results in increased expression of CD2AP protein] | decreases reaction|increases expression | 16636307
|
D011241 |
Prednisone |
Prednisone affects the reaction [Doxorubicin results in increased expression of CD2AP mRNA] | affects reaction|increases expression | 16636307
|
D011241 |
Prednisone |
Prednisone inhibits the reaction [Doxorubicin results in increased expression of CD2AP protein] | decreases reaction|increases expression | 16636307
|
D011691 |
Puromycin |
Puromycin results in decreased expression of CD2AP mRNA | decreases expression | 15673299
|
D014212 |
Tretinoin |
Tretinoin affects the reaction [Doxorubicin results in increased expression of CD2AP mRNA] | affects reaction|increases expression | 16636307
|
D014212 |
Tretinoin |
Tretinoin inhibits the reaction [Doxorubicin results in increased expression of CD2AP protein] | decreases reaction|increases expression | 16636307
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
11.96 | 18287403 |
MESH:D000138 |
Acidosis |
|
Lisinopril |
11.96 | 20061926 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.60 | 17418594 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.74 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.75 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
marker/mechanism |
|
| 21460841 21460840 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.11 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.18 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.30 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.39 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.60 | 16935849 |
MESH:D001607 |
Berylliosis |
|
Prednisone |
5.64 | 18757698 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.78 | 16206674 16197459 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.96 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.97 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.30 | 15668708 18695136 15136595 15939500 18628466 16826403 17983394 16264153 17369602 16595493 16096432 15634643 11325840 15993339 19526202 16322301 15994142 15692762 16115903 16935488 18382427 15567936 17426702 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.30 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.83 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.08 | 16051944 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.42 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
9.13 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
9.13 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
9.13 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
9.13 | 16023760 18059187 17876044 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
9.13 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.23 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.93 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.93 | 16096774 16051514 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.64 | 17519947 17924179 18627295 17928571 16269455 16952015 17351982 16651473 16364871 15792986 15505089 16731534 17131338 15811867 16109756 16612575 17007740 17382496 15476868 17974986 17308081 16278810 17329180 16242529 16455267 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.99 | 16243910 17334414 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.54 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.54 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.88 | 6135515 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.83 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.42 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.73 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.92 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.82 | 9142499 17551590 9125849 8800419 14991402 10589399 9664655 9211117 9224671 16925845 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.63 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.63 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.54 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.54 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.54 | 11739529 19085960 11529661 16177239 12594235 12705907 19923254 16081117 12540782 17522070 15619225 11421492 19164858 14725611 19420014 16781746 17906064 11834606 11743745 16227642 18713872 11461765 11287661 18071297 14550746 14986274 12153990 19416960 19739265 16109766 2444490 12958197 10663392 16485898 10915739 10774834 17562736 19370779 16393943 12392966 15968718 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
cyanoginosin LR |
12.54 | 17654400 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
12.54 | 17416283 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.36 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.79 | 18602426 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.73 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.95 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.95 | 16569247 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.42 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Prednisone |
5.58 | 16111148 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.70 | 16938888 9664655 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.83 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.73 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.94 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.60 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.60 | 17312396 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
marker/mechanism |
|
| |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
8.22 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
8.22 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.42 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.98 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.60 | 18674790 16244371 17875725 16144979 16707910 17888722 16244372 16330681 16495754 16879835 18006777 12587719 14766674 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.44 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.07 | 15692506 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
8.64 | 17606976 18501091 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
Prednisone |
8.64 | 16135485 17606976 16794504 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
8.09 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.09 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.78 | 16778211 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Lisinopril |
6.98 | 15811171 |
MESH:D007249 |
Inflammation |
|
Prednisone |
4.36 | 16111148 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.98 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.07 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
10.95 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
10.95 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Lisinopril |
10.95 | 12164870 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.33 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.85 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.85 | 16705839 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.84 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.42 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.87 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.10 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.26 | 17217047 17301526 15748426 19075265 17107899 16766008 16331271 16788101 16140955 19225113 19642359 16935935 17339181 17368321 17649720 12679006 17712046 17506722 16891316 19029980 9834237 17361223 19035177 17294898 16823087 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.43 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.99 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lisinopril |
3.99 | 17900296 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.99 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.66 | 19784758 19460945 11587558 12969438 16611625 19014921 16610002 12587719 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.40 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.21 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.41 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.41 | 17085340 16842330 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.15 | 6189445 17418594 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.58 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.93 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.78 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.13 | 15458769 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.84 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.52 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.52 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.78 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.64 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.12 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.67 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.03 | 17415656 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.17 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.01 | 15857846 19429709 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.15 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.15 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.01 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.48 | 16946489 16594593 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.98 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.15 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.98 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.16 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.34 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.01 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.43 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.43 | 16049721 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.25 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.39 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
7.07 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
7.07 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.51 | 15976015 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.42 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.42 | 17638057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
4.02 | 16729912 15897917 18437689 16868541 15749863 16888761 |
MESH:D011471 |
Prostatic Neoplasms |
|
Prednisone |
4.02 | 16888761 |
MESH:D011507 |
Proteinuria |
|
Lisinopril |
17.06 | 20061926 12164870 16636307 |
MESH:D011507 |
Proteinuria |
|
Prednisone |
17.06 | 16636307 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
17.06 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.03 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Lisinopril |
4.98 | 16458281 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.44 | 17922066 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.28 | 16116481 16283617 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.15 | 17203757 17710206 18313854 16767912 15625365 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.44 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.03 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.25 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.25 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.14 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
6.14 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.78 | 17203757 15625365 16767912 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.75 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.75 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.95 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.33 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.70 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.70 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.70 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.80 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.80 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.16 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.84 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.88 | 16752155 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.44 | 17638931 16364871 17334414 17678736 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.25 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.12 | 16287080 |